Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This is a randomised, placebo-controlled, double-blind study to assess the efficacy and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma.
Epistemonikos ID: f4df6f4dcfebcaab64320c84f17351aa53179116
First added on: Oct 02, 2023